MoneyWorks4Me

Colinz Laboratories - Quaterly Results

31 Jan 2022 Evaluate
The Revenue for the quarter ended  December 2021 of Rs. 15.91 millions grew by 6.21 % from Rs. 14.98 millions.The Net Profit of the company vaulted to 203.45% to Rs. 0.88  millions from Rs. 0.29 millions in the previous quarter.Operating profit surged to 1.84 millions from the corresponding previous quarter of 1.11 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 15.91 14.98 6.21 53.92 45.22 19.24 61.59 76.03 -18.99
Other Income 0.29 0.29 0.00 0.99 1.19 -16.81 1.91 1.35 41.48
PBIDT 1.84 1.11 65.77 5.71 3.89 46.79 5.22 4.38 19.18
Interest 0.23 0.25 -8.00 0.62 0.62 0.00 0.87 0.67 29.85
PBDT 1.61 0.86 87.21 5.09 3.27 55.66 4.35 3.71 17.25
Depreciation 0.51 0.49 4.08 1.51 1.41 7.09 1.91 1.95 -2.05
PBT 1.10 0.37 197.30 3.58 1.86 92.47 2.44 1.76 38.64
TAX 0.22 0.08 175.00 0.87 0.38 128.95 0.38 0.46 -17.39
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.40 -0.24 66.67
PAT 0.88 0.29 203.45 2.71 1.48 83.11 2.06 1.30 58.46
Equity 45.71 45.71 0.00 45.71 45.71 0.00 35.44 35.44 0.00
PBIDTM(%) 11.57 7.41 56.07 10.59 8.60 23.10 8.48 5.76 47.12
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..